Sara I McClelland1, Kathryn J Holland2, Jennifer J Griggs3. 1. Departments of Psychology and Women's Studies, University of Michigan, 204 South State St., Ann Arbor, MI, 48109, USA. saramcc@umich.edu. 2. Departments of Psychology and Women's Studies, University of Michigan, 204 South State St., Ann Arbor, MI, 48109, USA. 3. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School and Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Abstract
PURPOSE: Too little is understood about the quality of life (QoL) concerns of patients diagnosed with advanced disease. While body image has been found to be consistently important for women with early-stage breast cancer, the impact of body image on women with metastatic breast cancer (MBC) is less frequently studied. This cross-sectional study aimed to identify factors affecting QoL in a sample of patients diagnosed with MBC, with particular attention to body image, disease site, and time since diagnosis. METHODS: In total, 113 women diagnosed with MBC completed two QoL scales (EORTC QLQ30; EORTC BR23) as part of a larger study. Clinical characteristics were obtained via medical record review. Demographics, disease characteristics, and clinical factors were examined. RESULTS: Time since diagnosis and location of metastases were found to affect patients' QoL, and most strikingly, this effect often differed for those with higher and lower body image. Body image appears to remain highly influential even for those living with a shortened life expectancy. CONCLUSIONS: These findings indicate that the development of QoL support should more carefully consider patients diagnosed with MBC and the unique sets of body concerns that affect this population.
PURPOSE: Too little is understood about the quality of life (QoL) concerns of patients diagnosed with advanced disease. While body image has been found to be consistently important for women with early-stage breast cancer, the impact of body image on women with metastatic breast cancer (MBC) is less frequently studied. This cross-sectional study aimed to identify factors affecting QoL in a sample of patients diagnosed with MBC, with particular attention to body image, disease site, and time since diagnosis. METHODS: In total, 113 women diagnosed with MBC completed two QoL scales (EORTC QLQ30; EORTC BR23) as part of a larger study. Clinical characteristics were obtained via medical record review. Demographics, disease characteristics, and clinical factors were examined. RESULTS: Time since diagnosis and location of metastases were found to affect patients' QoL, and most strikingly, this effect often differed for those with higher and lower body image. Body image appears to remain highly influential even for those living with a shortened life expectancy. CONCLUSIONS: These findings indicate that the development of QoL support should more carefully consider patients diagnosed with MBC and the unique sets of body concerns that affect this population.
Entities:
Keywords:
Body image; Breast cancer; Metastatic; Middle age; Oncology; Quality of life
Authors: Pat Fobair; Susan L Stewart; Subo Chang; Carol D'Onofrio; Priscilla J Banks; Joan R Bloom Journal: Psychooncology Date: 2006-07 Impact factor: 3.894
Authors: M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson Journal: J Clin Oncol Date: 1996-10 Impact factor: 44.544
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: R Largillier; J-M Ferrero; J Doyen; J Barriere; M Namer; V Mari; A Courdi; J M Hannoun-Levi; F Ettore; I Birtwisle-Peyrottes; C Balu-Maestro; P Y Marcy; I Raoust; M Lallement; E Chamorey Journal: Ann Oncol Date: 2008-07-17 Impact factor: 32.976
Authors: Sharon H Giordano; Aman U Buzdar; Terry L Smith; Shu-Wan Kau; Ying Yang; Gabriel N Hortobagyi Journal: Cancer Date: 2004-01-01 Impact factor: 6.860
Authors: Shoshana M Rosenberg; Rulla M Tamimi; Shari Gelber; Kathryn J Ruddy; Sandra Kereakoglow; Virginia F Borges; Steven E Come; Lidia Schapira; Eric P Winer; Ann H Partridge Journal: Psychooncology Date: 2012-11-07 Impact factor: 3.894
Authors: Nadia A Nabulsi; Khatija W Naing; Huiwen Deng; Jenilee Cueto; Alemseged A Asfaw; Colin C Hubbard; Jifang Zhou; Inyoung Lee; Debanjali Mitra; Gregory S Calip; Ernest H Law Journal: J Patient Exp Date: 2022-07-11
Authors: Wanderson Divino Nilo Dos Santos; Paulo Gentil; Rafael Felipe de Moraes; João Batista Ferreira Júnior; Mário Hebling Campos; Claudio Andre Barbosa de Lira; Ruffo Freitas Júnior; Martim Bottaro; Carlos Alexandre Vieira Journal: Biomed Res Int Date: 2017-08-01 Impact factor: 3.411
Authors: Peh Joo Ho; Mikael Hartman; Danny A Young-Afat; Sofie A M Gernaat; Soo Chin Lee; Helena M Verkooijen Journal: PLoS One Date: 2018-02-21 Impact factor: 3.240
Authors: Mireia Margelí Vila; Sonia Del Barco Berron; Miguel Gil-Gil; Cristian Ochoa-Arnedo; Rafael Villanueva Vázquez Journal: Breast Date: 2020-06-26 Impact factor: 4.380
Authors: Manraj Kaur; Andrea L Pusic; Stefan J Cano; Feng Xie; Louise Bordeleau; Toni Zhong; Anne Klassen Journal: BMJ Open Date: 2020-01-07 Impact factor: 2.692
Authors: Anouk K M Claessens; Bram L T Ramaekers; Dorien J A Lobbezoo; Roel J W van Kampen; Maaike de Boer; Agnes J van de Wouw; M Wouter Dercksen; Sandra M E Geurts; Manuela A Joore; Vivianne C G Tjan-Heijnen Journal: Qual Life Res Date: 2020-08-20 Impact factor: 4.147